GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEF) » Definitions » FCF Margin %

Ipsen (IPSEF) FCF Margin % : 19.40% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Ipsen FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ipsen's Free Cash Flow for the six months ended in Dec. 2023 was $356 Mil. Ipsen's Revenue for the six months ended in Dec. 2023 was $1,836 Mil. Therefore, Ipsen's FCF Margin % for the quarter that ended in Dec. 2023 was 19.40%.

As of today, Ipsen's current FCF Yield % is 7.21%.

The historical rank and industry rank for Ipsen's FCF Margin % or its related term are showing as below:

IPSEF' s FCF Margin % Range Over the Past 10 Years
Min: -3.26   Med: 12.5   Max: 23.48
Current: 20.65

During the past 13 years, the highest FCF Margin % of Ipsen was 23.48%. The lowest was -3.26%. And the median was 12.50%.

IPSEF's FCF Margin % is ranked better than
91.42% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs IPSEF: 20.65

Ipsen FCF Margin % Historical Data

The historical data trend for Ipsen's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen FCF Margin % Chart

Ipsen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.89 23.48 17.30 22.76 20.66

Ipsen Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.81 20.79 24.54 21.96 19.40

Competitive Comparison of Ipsen's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipsen's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ipsen's FCF Margin % falls into.


Ipsen FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ipsen's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=744.82/3605.671
=20.66 %

Ipsen's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=356.162/1835.66
=19.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipsen FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ipsen's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen (IPSEF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEF) » Definitions » FCF Margin %
Comparable Companies
XPAR:VETO XPAR:BOI XPAR:EAPI XPAR:AB XPAR:MLCOT XPAR:ALRPD ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB BOM:500124
Traded in Other Exchanges
IPSEY:USA 0MH6:UK IPN:France I7G:Germany I7G:Germany
Address
65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100
Website
https://www.ipsen.com
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.